Although previous research, such as that by Sun et al. hinted at ZEB1 regulation by TCF4 contributing to drug resistance and stemness in CRC (Sun et al., 2020), the specific mechanism by which ZEB1 influences CRC prognosis remains unclear. This evidence concerns the gene TCF4 and colorectal carcinoma.